• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭治疗的性别差异。

Sex Differences in Advanced Heart Failure Therapies.

机构信息

Heart and Vascular Institute at the Cleveland Clinic, OH. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, OH.

出版信息

Circulation. 2019 Feb 19;139(8):1080-1093. doi: 10.1161/CIRCULATIONAHA.118.037369.

DOI:10.1161/CIRCULATIONAHA.118.037369
PMID:30779645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6383806/
Abstract

This in-depth review of sex differences in advanced heart failure therapy summarizes the existing literature on implantable cardioverter defibrillators, biventricular pacemakers, mechanical circulatory support, and transplantation with a focus on utilization, efficacy/clinical effectiveness, adverse events, and controversies. One will learn about the controversies regarding efficacy/clinical effectiveness of implantable cardioverter defibrillators and understand why these devices should be implanted in women even if there are sex differences in appropriate shocks. Individuals will learn about the sex differences with biventricular pacemakers with respect to ventricular remodeling and reduction in heart failure hospitalizations/mortality, as well as, possible mechanisms. We will demonstrate sex differences in heart transplantation and waitlist survival. Despite similar survival for women and men with left ventricular assist devices, there are sex differences in adverse events. These devices do successfully bridge women and men to transplant, yet women are less likely than men to have a left ventricular assist at time of listing and time of transplantation. Finally, one will learn about the concerns regarding poor outcome for men who receive female donor hearts and discover this may not be due to sex, but rather size. More research is needed to better understand sex differences and further improve advanced heart failure therapy for both women and men.

摘要

这篇深入探讨心力衰竭晚期治疗中性别差异的综述总结了有关植入式心脏复律除颤器、双心室起搏器、机械循环支持和移植的现有文献,重点关注了这些治疗方法的应用、疗效/临床效果、不良事件和争议。读者将了解到关于植入式心脏复律除颤器疗效/临床效果的争议,并明白为何即便电击存在性别差异,这些设备仍应植入女性体内。此外,读者还将了解到双心室起搏器在心室重构和心力衰竭住院/死亡率降低方面的性别差异,以及可能的机制。我们将展示心脏移植和候补名单存活率方面的性别差异。尽管女性和男性在使用左心室辅助装置后的生存率相似,但在不良事件方面仍存在性别差异。这些设备确实成功地将女性和男性桥接至移植,但与男性相比,女性在候补名单和移植时更不可能使用左心室辅助装置。最后,读者将了解到有关男性接受女性供体心脏后预后不佳的担忧,并发现这可能不是由于性别,而是由于心脏大小的差异。需要进一步研究以更好地了解性别差异,并进一步改善女性和男性的心力衰竭晚期治疗。

相似文献

1
Sex Differences in Advanced Heart Failure Therapies.心力衰竭治疗的性别差异。
Circulation. 2019 Feb 19;139(8):1080-1093. doi: 10.1161/CIRCULATIONAHA.118.037369.
2
Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.性别差异在植入式心脏复律除颤器植入适应证和结局中的作用:来自以色列全国 ICD 登记处的经验。
Europace. 2014 Aug;16(8):1175-80. doi: 10.1093/europace/euu015. Epub 2014 Feb 19.
3
Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.在一个大型全国队列中,植入起搏器、除颤器和心脏再同步治疗设备后女性与男性的生存率比较
J Am Heart Assoc. 2017 May 10;6(5):e005031. doi: 10.1161/JAHA.116.005031.
4
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.
5
Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.女性与男性的心脏再同步治疗:来自国家心血管数据登记处的观察性比较疗效研究。
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S4-11. doi: 10.1161/CIRCOUTCOMES.114.001548. Epub 2015 Feb 24.
6
Cardiac Implantable Electronic Device Therapy in Heart Failure.心力衰竭的心脏植入式电子设备治疗。
Circ Res. 2019 May 24;124(11):1584-1597. doi: 10.1161/CIRCRESAHA.118.313571.
7
Safety and Effectiveness of Medical Device Therapy.医疗器械治疗的安全性和有效性。
Adv Exp Med Biol. 2018;1065:107-121. doi: 10.1007/978-3-319-77932-4_7.
8
Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.多中心心脏再同步治疗自动除颤器植入试验(MADIT-CRT)中室性心律失常或死亡的器械治疗的性别差异
J Cardiovasc Electrophysiol. 2015 Aug;26(8):862-871. doi: 10.1111/jce.12701. Epub 2015 Jun 17.
9
Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.使用和不使用植入式心脏复律除颤器的心脏再同步治疗中的机构层面差异与临床结局
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004763. doi: 10.1161/CIRCOUTCOMES.118.004763.
10
Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.植入式心脏复律除颤器治疗中房颤的作用:死亡、恰当及不恰当电击的危险因素
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1116-22. doi: 10.1111/jce.12208. Epub 2013 Jul 25.

引用本文的文献

1
Are There Gender Differences in the Benefits of Multidisciplinary Care in Patients with Heart Failure? Results from the UMIPIC Program.心力衰竭患者多学科护理的益处是否存在性别差异?UMIPIC项目的结果。
J Clin Med. 2025 Aug 17;14(16):5818. doi: 10.3390/jcm14165818.
2
Impella 5.5 use in women: A multicenter study.女性使用Impella 5.5:一项多中心研究。
JHLT Open. 2025 Jul 10;9:100341. doi: 10.1016/j.jhlto.2025.100341. eCollection 2025 Aug.
3
Does race influence health-related quality of life outcomes in older patients who undergo advanced cardiac surgical therapies?

本文引用的文献

1
HVAD: The ENDURANCE Supplemental Trial.HVAD:ENDURANCE 补充试验。
JACC Heart Fail. 2018 Sep;6(9):792-802. doi: 10.1016/j.jchf.2018.05.012. Epub 2018 Jul 11.
2
Sex-Specific Response to Cardiac Resynchronization Therapy: Effect of Left Ventricular Size and QRS Duration in Left Bundle Branch Block.性别对心脏再同步治疗的反应:左束支传导阻滞中左心室大小和 QRS 持续时间的影响。
JACC Clin Electrophysiol. 2017 Aug;3(8):844-853. doi: 10.1016/j.jacep.2017.02.021. Epub 2017 Apr 26.
3
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
种族会影响接受晚期心脏外科治疗的老年患者与健康相关的生活质量结果吗?
JHLT Open. 2025 May 13;9:100286. doi: 10.1016/j.jhlto.2025.100286. eCollection 2025 Aug.
4
Race, Genetics, and Social Determinants of Health in Transthyretin Cardiac Amyloidosis: A Literature Review and Call to Action.转甲状腺素蛋白心脏淀粉样变中的种族、遗传学与健康的社会决定因素:文献综述与行动呼吁
Curr Cardiol Rep. 2025 Mar 5;27(1):66. doi: 10.1007/s11886-025-02220-z.
5
Multicenter study for CH-VAD as a fully magnetically levitated left ventricular assist device.CH-VAD作为全磁悬浮左心室辅助装置的多中心研究。
iScience. 2025 Jan 7;28(2):111764. doi: 10.1016/j.isci.2025.111764. eCollection 2025 Feb 21.
6
Sex-related differences in heart failure patients: physiological mechanisms of cardiovascular ageing and evidence-based sex-specific medical therapies.心力衰竭患者的性别差异:心血管衰老的生理机制及循证医学支持的性别特异性治疗方法
Ther Adv Cardiovasc Dis. 2025 Jan-Dec;19:17539447241309673. doi: 10.1177/17539447241309673.
7
Specificities of Myocardial Infarction and Heart Failure in Women.女性心肌梗死与心力衰竭的特异性
J Clin Med. 2024 Dec 2;13(23):7319. doi: 10.3390/jcm13237319.
8
Impact of biological sex on heart transplant patients admitted to cardiac rehabilitation: A 10-year retrospective cohort study.生物性别对接受心脏康复治疗的心脏移植患者的影响:一项为期10年的回顾性队列研究。
Int J Cardiol Cardiovasc Risk Prev. 2024 Oct 17;23:200345. doi: 10.1016/j.ijcrp.2024.200345. eCollection 2024 Dec.
9
Advanced Heart Failure Characteristics and Outcomes in Women and Men.女性和男性的晚期心力衰竭特征和结局。
J Am Heart Assoc. 2024 Jul 2;13(13):e033374. doi: 10.1161/JAHA.123.033374. Epub 2024 Jun 21.
10
Sex and Gender-related Disparities in Clinical Characteristics and Outcomes in Heart Transplantation.心脏移植中与性别相关的临床特征和结局的性别差异。
Curr Heart Fail Rep. 2024 Aug;21(4):367-378. doi: 10.1007/s11897-024-00670-0. Epub 2024 Jun 11.
磁悬浮离心泵治疗心力衰竭的两年结果。
N Engl J Med. 2018 Apr 12;378(15):1386-1395. doi: 10.1056/NEJMoa1800866. Epub 2018 Mar 11.
4
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.《2018年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31.
5
OPTN/SRTR 2016 Annual Data Report: Heart.OPTN/SRTR 2016 年度数据报告:心脏。
Am J Transplant. 2018 Jan;18 Suppl 1:291-362. doi: 10.1111/ajt.14561.
6
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.在 MOMENTUM 3 试验中,年龄、性别、治疗意图、种族和晚期心力衰竭严重程度对短期主要结局的影响。
J Heart Lung Transplant. 2018 Jan;37(1):7-14. doi: 10.1016/j.healun.2017.11.001. Epub 2017 Nov 3.
7
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries.原发性预防植入式心脏复律除颤器治疗的结局中的性别差异:来自 11 个欧洲国家的联合登记数据。
Europace. 2018 Jun 1;20(6):963-970. doi: 10.1093/europace/eux176.
8
INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.INTERMACS 分析持续性左心室辅助装置支持期间的卒中:危险因素和结果。
JACC Heart Fail. 2017 Oct;5(10):703-711. doi: 10.1016/j.jchf.2017.06.014.
9
Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes.心力衰竭住院合格患者心脏再同步治疗的应用及其与患者预后的关联。
Am Heart J. 2017 Jul;189:48-58. doi: 10.1016/j.ahj.2017.04.001. Epub 2017 Apr 6.
10
Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation.等待心脏移植期间基于器官共享联合网络状态的死亡率性别差异
Circ Heart Fail. 2017 Jun;10(6). doi: 10.1161/CIRCHEARTFAILURE.116.003635.